Skip to main content

Abstract

This chapter focuses on the increasing environmental apprehensions and persistence of numerous organic contaminants so-called emerging contaminants (ECs), including biologically active elements from pharmaceutical source industries. Several types of diverse pharmaceutical-related compounds are being detected in environmental matrices and wastewater treatment units. Owing to this broader occurrence, transformation, and detection of pharmaceutical-related compounds in water matrices, people and legislative authorities are now more concerned about potential sources and ecological consequences of ECs. This is mainly because the free movement of ECs in water matrices is posing noteworthy adverse effects on human, aquatic animals, and naturally occurring plants, even at minimal concentrations. So far, several detection and treatment processes have been proposed and exploited against numerous pharmaceutical-related ECs. The useful and side effects of pharmaceutical-related compounds have been extensively inspected. Owing to this substantial research gap, the sources and environmental persistence of pharmaceutical-related ECs and their direct/indirect adverse effects have now been the topic of intensive studies. From the surface water perspective, wastewater treatment plants (WWTPs) are the major source of pharmaceutical-related ECs. The current chapter spotlights the widespread occurrence, numerous sources, and transportation fate of pharmaceutical-related ECs in water matrices.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Bilal M, Ashraf SS, Barceló D, Iqbal HM (2019) Biocatalytic degradation/redefining “removal” fate of pharmaceutically active compounds and antibiotics in the aquatic environment. Sci Total Environ 691:1190–1211

    CAS  Google Scholar 

  2. Pylypchuk IV, Daniel G, Kessler VG, Seisenbaeva GA (2020) Removal of diclofenac, paracetamol, and carbamazepine from model aqueous solutions by magnetic Sol–Gel encapsulated horseradish peroxidase and lignin peroxidase composites. Nano 10(2):282

    CAS  Google Scholar 

  3. Bilal M, Mehmood S, Rasheed T, Iqbal HM (2020) Antibiotics traces in the aquatic environment: persistence and adverse environmental impact. Curr Opin Environ Sci Health 13:68–74

    Google Scholar 

  4. Ebele AJ, Abdallah MAE, Harrad S (2017) Pharmaceuticals and personal care products (PPCPs) in the freshwater aquatic environment. Emerg Contam 3(1):1–16

    Google Scholar 

  5. Miarov O, Tal A, Avisar D (2020) A critical evaluation of comparative regulatory strategies for monitoring pharmaceuticals in recycled wastewater. J Environ Manag 254:109794

    CAS  Google Scholar 

  6. Stroski KM, Luong KH, Challis JK, Chaves-Barquero LG, Hanson ML, Wong CS (2020) Wastewater sources of per-and polyfluorinated alkyl substances (PFAS) and pharmaceuticals in four Canadian Arctic communities. Sci Total Environ 708:134494

    CAS  Google Scholar 

  7. Li WC (2014) Occurrence, sources, and fate of pharmaceuticals in aquatic environment and soil. Environ Pollut 187:193–201

    CAS  Google Scholar 

  8. Petrović M, Gonzalez S, Barceló D (2003) Analysis and removal of emerging contaminants in wastewater and drinking water. TrAC Trends Anal Chem 22(10):685–696

    Google Scholar 

  9. Tixier C, Singer HP, Oellers S, Müller SR (2003) Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters. Environ Sci Technol 37(6):1061–1068

    CAS  Google Scholar 

  10. Aldekoa J, Medici C, Osorio V, Pérez S, Marcé R, Barceló D, Francés F (2013) Modelling the emerging pollutant diclofenac with the GREAT-ER model: application to the Llobregat River basin. J Hazard Mater 263:207–213

    CAS  Google Scholar 

  11. Buser HR, Poiger T, Müller MD (1998) Occurrence and fate of the pharmaceutical drug diclofenac in surface waters: rapid photodegradation in a lake. Environ Sci Technol 32(22):3449–3456

    CAS  Google Scholar 

  12. Hallgren P, Wallberg P (2015) Background report on pharmaceutical concentrations and effects in the Baltic Sea. In: Policy area hazards of the EU strategy for the Baltic Sea region. Swedish Environmental Protection Agency, Stockholm

    Google Scholar 

  13. Belhaj D, Baccar R, Jaabiri I, Bouzid J, Kallel M, Ayadi H, Zhou JL (2015) Fate of selected estrogenic hormones in an urban sewage treatment plant in Tunisia (North Africa). Sci Total Environ 505:154–160

    CAS  Google Scholar 

  14. Morsi R, Bilal M, Iqbal HM, Ashraf SS (2020) Laccases and peroxidases: the smart, greener and futuristic biocatalytic tools to mitigate recalcitrant emerging pollutants. Sci Total Environ 714:136572

    CAS  Google Scholar 

  15. Lapworth DJ, Baran N, Stuart ME, Ward RS (2012) Emerging organic contaminants in groundwater: a review of sources, fate and occurrence. Environ Pollut 163:287–303

    CAS  Google Scholar 

  16. Bueno MM, Gomez MJ, Herrera S, Hernando MD, Agüera A, Fernández-Alba AR (2012) Occurrence and persistence of organic emerging contaminants and priority pollutants in five sewage treatment plants of Spain: two years pilot survey monitoring. Environ Pollut 164:267–273

    CAS  Google Scholar 

  17. Boxall AB (2004) The environmental side effects of medication: how are human and veterinary medicines in soils and water bodies affecting human and environmental health? EMBO Rep 5(12):1110–1116

    CAS  Google Scholar 

  18. Carvalho IT, Santos L (2016) Antibiotics in the aquatic environments: a review of the European scenario. Environ Int 94:736–757

    Google Scholar 

  19. Daniels K, Daugherty JD, Jones J, Mosher WD (2015) Current contraceptive use and variation by selected characteristics among women aged 15-44: United States, 2011-2013. Natl Health Stat Rep 86:1–15

    Google Scholar 

  20. Daniels K, Mosher WD, Jones J (2013) Contraceptive methods women have ever used: United States, 1982-2010. Natl Health Stat Rep 62:1–15

    Google Scholar 

  21. Kavanaugh ML, Jerman J (2018) Contraceptive method use in the United States: trends and characteristics between 2008, 2012 and 2014. Contraception 97(1):14–21

    Google Scholar 

  22. Mosher WD, Jones J (2010) Use of contraception in the United States: 1982-2008. In: Vital and health statistics. Series 23, data from the national survey of family growth, vol 29, pp 1–44

    Google Scholar 

  23. Metcalfe C, Miao XS, Hua W, Letcher R, Servos M (2004) Pharmaceuticals in the Canadian environment. In: Pharmaceuticals in the environment. Springer, Berlin, pp 67–90

    Google Scholar 

  24. Mellon M, Benbrook C, Benbrook KL (2001) Hogging it: estimates of antimicrobial abuse in livestock. Union of Concerned Scientists, Cambridge

    Google Scholar 

  25. Nawaz MS, Erickson BD, Khan AA, Khan SA, Pothuluri JV, Rafii F et al (2002) Human health impact and regulatory issues involving antimicrobial resistance in the food animal production environment. Res Perspect J 1(1):1–10

    Google Scholar 

  26. Korada SK, Yarla NS, Putta S, Hanumakonda AS, Lakkappa DB, Bishayee A et al (2018) A critical appraisal of different food safety and quality management tools to accomplish food safety. In: Food safety and preservation. Academic Press, San Diego, pp 1–12. https://doi.org/10.1016/B978-0-12-814956-0.00001-9

    Chapter  Google Scholar 

  27. Akici A, Aydin V, Kiroglu A (2018) Assessment of the association between drug disposal practices and drug use and storage behaviors. Saudi Pharm J 26(1):7–13

    Google Scholar 

  28. Ben Y, Fu C, Hu M, Liu L, Wong MH, Zheng C (2019) Human health risk assessment of antibiotic resistance associated with antibiotic residues in the environment: a review. Environ Res 169:483–493

    CAS  Google Scholar 

  29. de Oliveira M, Frihling BEF, Velasques J, Magalhães Filho FJC, Cavalheri PS, Migliolo L (2020) Pharmaceuticals residues and xenobiotics contaminants: occurrence, analytical techniques and sustainable alternatives for wastewater treatment. Sci Total Environ 705:135568

    Google Scholar 

  30. Glassmeyer ST, Furlong ET, Kolpin DW, Cahill JD, Zaugg SD, Werner SL et al (2005) Transport of chemical and microbial compounds from known wastewater discharges: potential for use as indicators of human fecal contamination. Environ Sci Technol 39(14):5157–5169

    CAS  Google Scholar 

  31. He K, Borthwick AG, Lin Y, Li Y, Fu J, Wong Y, Liu W (2020) Sale-based estimation of pharmaceutical concentrations and associated environmental risk in the Japanese wastewater system. Environ Int 139:105690

    CAS  Google Scholar 

  32. Kümmerer K (2010) Pharmaceuticals in the environment. Annu Rev Environ Resour 35:57–75

    Google Scholar 

  33. Azuma T, Otomo K, Kunitou M, Shimizu M, Hosomaru K, Mikata S et al (2019) Environmental fate of pharmaceutical compounds and antimicrobial-resistant bacteria in hospital effluents, and contributions to pollutant loads in the surface waters in Japan. Sci Total Environ 657:476–484

    CAS  Google Scholar 

  34. Hanamoto S, Nakada N, Yamashita N, Tanaka H (2018) Source estimation of pharmaceuticals based on catchment population and in-stream attenuation in Yodo River watershed, Japan. Sci Total Environ 615:964–971

    CAS  Google Scholar 

  35. Čelić M, Gros M, Farré M, Barceló D, Petrović M (2019) Pharmaceuticals as chemical markers of wastewater contamination in the vulnerable area of the Ebro Delta (Spain). Sci Total Environ 652:952–963

    Google Scholar 

  36. Kostich MS, Batt AL, Lazorchak JM (2014) Concentrations of prioritized pharmaceuticals in effluents from 50 large wastewater treatment plants in the US and implications for risk estimation. Environ Pollut 184:354–359

    CAS  Google Scholar 

  37. Liu JL, Wong MH (2013) Pharmaceuticals and personal care products (PPCPs): a review on environmental contamination in China. Environ Int 59:208–224

    CAS  Google Scholar 

  38. Munro K, Martins CP, Loewenthal M, Comber S, Cowan DA, Pereira L, Barron LP (2019) Evaluation of combined sewer overflow impacts on short-term pharmaceutical and illicit drug occurrence in a heavily urbanised tidal river catchment (London, UK). Sci Total Environ 657:1099–1111

    CAS  Google Scholar 

  39. Spataro F, Ademollo N, Pescatore T, Rauseo J, Patrolecco L (2019) Antibiotic residues and endocrine disrupting compounds in municipal wastewater treatment plants in Rome, Italy. Microchem J 148:634–642

    CAS  Google Scholar 

  40. Thalla AK, Vannarath AS (2020) Occurrence and environmental risks of non-steroidal anti-inflammatory drugs in urban wastewater in the southwest monsoon region of India. Environ Monit Assess 192(3):1–13

    Google Scholar 

  41. Felis E, Kalka J, Sochacki A, Kowalska K, Bajkacz S, Harnisz M, Korzeniewska E (2020) Antimicrobial pharmaceuticals in the aquatic environment-occurrence and environmental implications. Eur J Pharmacol 866:172813

    CAS  Google Scholar 

  42. Nantaba F, Wasswa J, Kylin H, Palm WU, Bouwman H, Kümmerer K (2020) Occurrence, distribution, and ecotoxicological risk assessment of selected pharmaceutical compounds in water from Lake Victoria, Uganda. Chemosphere 239:124642

    CAS  Google Scholar 

  43. Su D, Ben W, Strobel BW, Qiang Z (2020) Occurrence, source estimation and risk assessment of pharmaceuticals in the Chaobai River characterized by adjacent land use. Sci Total Environ 712:134525

    CAS  Google Scholar 

  44. Reis EO, Foureaux AFS, Rodrigues JS, Moreira VR, Lebron YA, Santos LV et al (2019) Occurrence, removal and seasonal variation of pharmaceuticals in Brasilian drinking water treatment plants. Environ Pollut 250:773–781

    CAS  Google Scholar 

  45. Greenham RT, Miller KY, Tong A (2019) Removal efficiencies of top-used pharmaceuticals at sewage treatment plants with various technologies. J Environ Chem Eng 7(5):103294

    CAS  Google Scholar 

  46. Kleywegt S, Payne M, Ng F, Fletcher T (2019) Environmental loadings of active pharmaceutical ingredients from manufacturing facilities in Canada. Sci Total Environ 646:257–264

    CAS  Google Scholar 

  47. Kołecka K, Gajewska M, Stepnowski P, Caban M (2019) Spatial distribution of pharmaceuticals in conventional wastewater treatment plant with sludge treatment reed beds technology. Sci Total Environ 647:149–157

    Google Scholar 

  48. Afonso-Olivares C, Sosa-Ferrera Z, Santana-Rodríguez JJ (2017) Occurrence and environmental impact of pharmaceutical residues from conventional and natural wastewater treatment plants in Gran Canaria (Spain). Sci Total Environ 599:934–943

    Google Scholar 

  49. Liu HQ, Lam JC, Li WW, Yu HQ, Lam PK (2017) Spatial distribution and removal performance of pharmaceuticals in municipal wastewater treatment plants in China. Sci Total Environ 586:1162–1169

    CAS  Google Scholar 

  50. Harrison EZ, Oakes SR, Hysell M, Hay A (2006) Organic chemicals in sewage sludges. Sci Total Environ 367(2–3):481–497

    CAS  Google Scholar 

  51. Gunningham N, Sinclair D (2005) Policy instrument choice and diffuse source pollution. J Environ Law 17(1):51–81

    Google Scholar 

  52. Ribaudo M, Horan RD, Smith ME (1999) Economics of water quality protection from non-point sources; theory and practice. In: Ribaudo MO, Horan RD, Smith ME (eds) Agricultural economic report; no. 782 an economic research service report

    Google Scholar 

  53. Directive WF (2000) Directive 2000/60/EC of the European Parliament and of the Council of 23 October 2000 establishing a framework for community action in the field of water policy. Off J Eur Communities 22(12):2000

    Google Scholar 

  54. Ashton D, Hilton M, Thomas KV (2004) Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci Total Environ 333(1–3):167–184

    CAS  Google Scholar 

  55. Kolpin DW, Battaglin WA, Conn KE, Furlong ET, Glassmeyer ST, Kalkhoff SJ et al (2008) Occurrence of transformation products in the environment. In: Transformation products of synthetic chemicals in the environment. Springer, Berlin, pp 83–100

    Google Scholar 

  56. Nikolaou A, Meric S, Fatta D (2007) Occurrence patterns of pharmaceuticals in water and wastewater environments. Anal Bioanal Chem 387(4):1225–1234

    CAS  Google Scholar 

  57. Bendz D, Paxéus NA, Ginn TR, Loge FJ (2005) Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden. J Hazard Mater 122(3):195–204

    CAS  Google Scholar 

  58. Huang CH, Renew JE, Smeby KL, Pinkston K, Sedlak DL (2011) Assessment of potential antibiotic contaminants in water and preliminary occurrence analysis. J Contem Water Res Educ 120(1):4

    Google Scholar 

  59. Roberts PH, Thomas KV (2006) The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. Sci Total Environ 356(1–3):143–153

    CAS  Google Scholar 

  60. Lishman L, Smyth SA, Sarafin K, Kleywegt S, Toito J, Peart T et al (2006) Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada. Sci Total Environ 367(2–3):544–558

    CAS  Google Scholar 

  61. Angeles LF, Islam S, Aldstadt J, Saqeeb KN, Alam M, Khan MA et al (2020) Retrospective suspect screening reveals previously ignored antibiotics, antifungal compounds, and metabolites in Bangladesh surface waters. Sci Total Environ 712:136285

    CAS  Google Scholar 

  62. Carlsson C, Johansson AK, Alvan G, Bergman K, Kühler T (2006) Are pharmaceuticals potent environmental pollutants?: part I: environmental risk assessments of selected active pharmaceutical ingredients. Sci Total Environ 364(1–3):67–87

    CAS  Google Scholar 

  63. Gao XY, Liu Y, Miao LL, Liu ZP (2020) Pseudomonas sp. AOB-7 utilizes PHA granules as a sustained-release carbon source and biofilm carrier for aerobic denitrification of aquaculture water. Appl Microbiol Biotechnol 104(7):3183–3192

    CAS  Google Scholar 

Download references

Acknowledgments

The work is a part of the project entitled “Contaminantes emergentes y priori-tarios en las aguas reutilizadas en agricultura: riesgos y efectos en suelos, produc-ción agrícola y entorno ambiental” funded by CSIC-Tecnologico de Monterrey under iLink program. All listed authors are also grateful to their representative universities/institutes for providing literature facilities.

Conflict of Interest

Authors declare no conflict of interests in any capacity, including competing or financial.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hafiz M. N. Iqbal .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Parra-Saldivar, R., Castillo-Zacarías, C., Bilal, M., Iqbal, H.M.N., Barceló, D. (2020). Sources of Pharmaceuticals in Water. In: Pérez Solsona, S., Montemurro, N., Chiron, S., Barceló, D. (eds) Interaction and Fate of Pharmaceuticals in Soil-Crop Systems. The Handbook of Environmental Chemistry, vol 103. Springer, Cham. https://doi.org/10.1007/698_2020_623

Download citation

Publish with us

Policies and ethics